News
Video
Author(s):
Overview of hurdles and advancements in utilizing advanced imaging techniques for prostate cancer diagnosis, including agent availability, scheduling, facility preferences, and reimbursement.
AUA 2025: What to watch for in urologic oncology
Dr. Murphy on increasing diversity in cancer clinical trials
Dose expansion begins in phase 1/2 trial of 67Cu-SAR-bisPSMA in mCRPC
Dr. Schwen on focal therapies for prostate cancer
Polygenic risk score may identify more clinically significant PCa than PSA, MRI
Genetic test can predict risk of toxicity following radiation for prostate cancer